Concepedia

Philip Wastall

PW

Statistics

Publications

6

Citations

1.6K

H-Index

6

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Philip Wastall is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and atherosclerosis.

Top concepts

Publications per year

1997–2016

6

Publications

6

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data.

R. Scott Obach, James G. Baxter, Theodore E. Liston et al. · PubMed · 1997 · 638 citations

The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data

R. Scott Obach, James G. Baxter, Theodore E. Liston et al. · Journal of Pharmacology and Experimental Therapeutics · 1997 · 574 citations

, , +11

Beneficial and Adverse Effects of an LXR Agonist on Human Lipid and Lipoprotein Metabolism and Circulating Neutrophils

Todd G. Kirchgessner, Paul G. Sleph, Jacek Ostrowski et al. · Cell Metabolism · 2016 · 155 citations · Full text

, , +12

Comparative human pharmacokinetics and metabolism of single‐dose oral and intravenous sildenafil

Gary J. Muirhead, David J. Rance, Donald K. Walker et al. · British Journal of Clinical Pharmacology · 2002 · 119 citations · Full text

A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects

Jessie J. Wang, Yan Song, Janice Pursley et al. · Thrombosis and Haemostasis · 2012 · 54 citations

1–5 of 6